Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Paolo Orsini"'
Autor:
Davide La Rosa, Luca Bruschini, Maria Paola Tramonti Fantozzi, Paolo Orsini, Mario Milazzo, Antonino Crivello
Publikováno v:
Data, Vol 9, Iss 3, p 43 (2024)
Evaluating hearing in newborns and uncooperative patients can pose a considerable challenge. One potential solution might be to employ the Pupil Dilation Response (PDR) as an objective physiological metric. In this dataset descriptor paper, we presen
Externí odkaz:
https://doaj.org/article/f068c7ffbd534baf8469021b76346be2
Autor:
Claudia Grasso, Massimo Barresi, Maria Paola Tramonti Fantozzi, Francesco Lazzerini, Luca Bruschini, Stefano Berrettini, Paolo Andre, Cristina Dolciotti, Vincenzo De Cicco, Davide De Cicco, Paola d'Ascanio, Paolo Orsini, Francesco Montanari, Ugo Faraguna, Diego Manzoni
Publikováno v:
PLoS ONE, Vol 18, Iss 6, p e0287123 (2023)
The effects of postural training on postural stability and vestibulospinal reflexes (VSRs) were investigated in normal subjects. A period (23 minutes) of repeated episodes (n = 10, 50 seconds) of unipedal stance elicited a progressive reduction of th
Externí odkaz:
https://doaj.org/article/48a617ecaedc4868b079f29a339db8d2
Autor:
Emily Capone, Rossano Lattanzio, Fabio Gasparri, Paolo Orsini, Cosmo Rossi, Valentina Iacobelli, Vincenzo De Laurenzi, Pier Giorgio Natali, Barbara Valsasina, Stefano Iacobelli, Gianluca Sala
Publikováno v:
Pharmaceutics, Vol 13, Iss 4, p 483 (2021)
HER-3 is becoming an attractive target for antibody–drug conjugate (ADC)-based therapy. Indeed, this receptor and its ligands are found to be overexpressed in several malignancies, and re-activation of its downstream signaling axis is known to play
Externí odkaz:
https://doaj.org/article/cbdde89232044ed284a03558c3f68140
Autor:
Arturo Galvani, Paola Magnaghi, Enrico Pesenti, Antonella Isacchi, Daniele Donati, Eduard Felder, Gang Li, Jean-Michel Vernier, Jason Harris, Ge Wei, David Anderson, Luca Mologni, Tiziano Bandiera, Paolo Orsini, Daniele Casero, Maria Beatrice Saccardo, Nadia Amboldi, Nilla Avanzi, Anna Degrassi, Gemma Texido, Marina Ciomei, Dario Ballinari, Romana Pulci, Cristina De Ponti, Roberta Bosotti, Patrizia Banfi, Maria Menichincheri, Elena Ardini
Supplementary experimental procedures are described
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35e7349af36e6ac21496c6964180ab8f
https://doi.org/10.1158/1535-7163.22508037
https://doi.org/10.1158/1535-7163.22508037
Autor:
Arturo Galvani, Paola Magnaghi, Enrico Pesenti, Antonella Isacchi, Daniele Donati, Eduard Felder, Gang Li, Jean-Michel Vernier, Jason Harris, Ge Wei, David Anderson, Luca Mologni, Tiziano Bandiera, Paolo Orsini, Daniele Casero, Maria Beatrice Saccardo, Nadia Amboldi, Nilla Avanzi, Anna Degrassi, Gemma Texido, Marina Ciomei, Dario Ballinari, Romana Pulci, Cristina De Ponti, Roberta Bosotti, Patrizia Banfi, Maria Menichincheri, Elena Ardini
Supplementary Figure 1. Efficacy of entrectinib on KM12 xenograft model using the scheduling 4 days on/ 3 days off. Supplementary Figure 2. Mechanism of action of entrectinib compared to crizotinib in ALK-dependent Ba/F3 cells. Supplementary Figure 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f11ccf8c2eee09b004c4cb5d12e7089
https://doi.org/10.1158/1535-7163.22508040
https://doi.org/10.1158/1535-7163.22508040
Autor:
Grazia Saturno, Michele Modugno, Paolo Orsini, Giovanni Cervi, Laura Buffa, Ilaria Motto, Nilla Avanzi, Marisa Montemartini, Fabio Gasparri, Gemma Texido, Arturo Galvani, Antonella Isacchi
Publikováno v:
Cancer Research. 83:4036-4036
The B-cell receptor (BCR) is a key survival molecule for normal B cells and for most B-cell malignancies, such as Chronic Lymphocytic Leukaemia (CLL) and Non-Hodgkin’s Lymphomas (NHL) including Diffuse Large B-cell Lymphomas (DLBCL). Small molecule
Autor:
Fabio Gasparri, Gianluca Sala, Paolo Orsini, Barbara Valsasina, Emily Capone, Valentina Iacobelli, Rossano Lattanzio, Cosmo Rossi, Vincenzo De Laurenzi, Pier Giorgio Natali, Stefano Iacobelli
Publikováno v:
Pharmaceutics, Vol 13, Iss 483, p 483 (2021)
Pharmaceutics
Volume 13
Issue 4
Pharmaceutics
Volume 13
Issue 4
HER-3 is becoming an attractive target for antibody–drug conjugate (ADC)-based therapy. Indeed, this receptor and its ligands are found to be overexpressed in several malignancies, and re-activation of its downstream signaling axis is known to play
Autor:
Alessandra Cirla, Elena Casale, Nilla Avanzi, Marina Ciomei, Viviana Desperati, Helena Posteri, Eduard R. Felder, Gianluca Papeo, Alessia Montagnoli, Arturo Galvani, Marco Guanci, Daniela Borghi, Antonella Isacchi, Daniele Donati, Sonia Rainoldi, Alessandra Scolaro, Paolo Orsini, Federico Riccardi-Sirtori
Publikováno v:
ACS Medicinal Chemistry Letters. 10:534-538
[Image: see text] Poly(ADP-ribose) polymerase-1 (PARP-1) is an enzyme involved in signaling and repair of DNA single strand breaks. PARP-1 employs NAD(+) to modify substrate proteins via the attachment of poly(ADP-ribose) chains. PARP-1 is a well est
Publikováno v:
SSRN Electronic Journal.
This paper reports on numerical thermal studies of cold CO2 injection into the Bunter Closure 36 prospect, analysing temperature effects during the injection and assessing the time required by the aquifer to recover the initial natural temperature. F
Autor:
Andrea Zangrandi, Paolo Orsini, Francesca Diolaiuti, Laura Sebastiani, Alessandro Mioli, Enrica L. Santarcangelo
This study investigated multisensory integration in 29 medium-to-high (mid-highs) and 24 low-to-medium (mid-lows) hypnotizable individuals, classified according to the Stanford Hypnotic Susceptibility Scale, Form A. Participants completed a simultane
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c844f0cad51d5389bae79dbf0c5bf856
http://hdl.handle.net/11568/1072023
http://hdl.handle.net/11568/1072023